Expert's Opinion

Cold Chain Management | Logistics | Supply Chain

COVID-19: Bending, Not Breaking, Biopharma Supply Chains

The biopharma industry rose to address a multitude of supply chain challenges brought on by COVID.

Rick Lozano, Chief Commercial Officer, AeroSafe Global 10.25.21

Cold Chain Management | Supply Chain

The Evolution of Cold Supply Chains in the Wake of COVID-19

How the pharmaceutical industry implemented changes and how these changes continue to affect standard distribution practices.

Andrew Kirk, Chief Operating Officer at BioCare, Inc. 10.21.21

Clinical Trials | Information Technology

How to Run Decentralized Clinical Trials in the Complex Web of Data Protection

Lessons learned from operationalizing hybrid DCT solutions across the globe.

Ronan Brown, Ph.D., Head of Decentralized Trials Solutions at IQVIA 10.18.21

Drug Development

New Product Development: Outsourcing Single-Use Technologies to Accelerate Speed to Market

Developing SUT in parallel with drug product as it moves out of R&D, into clinical trials, and commercial manufacturing.

Del Williams, Intellitech, Inc. 10.15.21

Biologics, Proteins, Vaccines | Drug Development

CAR-T and Beyond: The Future of Adoptive Cell Therapies

CAR-T cells have shown incredible promise in the clinic, but when it comes to cell therapies, they’re just the beginning.

Mark White and Marwan Alsarraj , Bio-Rad Laboratories 10.12.21

Drug Development | Laboratory Testing

Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies

The importance of reagent quality control, especially endotoxin testing, during CGT development and the selection of reagents and suppliers to ensure safety.

Garrett Perry, Technical Services Specialists at Teknova 09.14.21

Clinical Trials | Drug Development

Supporting Product Regulatory Decision Making with RWE

Leveraging powerful evidence that can be instrumental in filling knowledge gaps for regulatory submissions.

Nancy Dreyer, Chief Scientific Officer at IQVIA Real World Solutions 09.10.21

cGMP Manufacture | Drug Development | QA/QC

Three Tips for Navigating Post-Approval Pharmacovigilance

Seamlessly transition from regulatory reporting to post-approval safety surveillance in today’s market.

Emmanuel Belabe, Associate Vice President, Safety Product Management, ArisGlobal, Nina Patel Lahanis, Associate Vice President, Safety Science, EVERSANA 09.08.21

Bioanalytical Services

Ensuring Equitable Access to Next-generation Sequencing in Oncology

Recent advances in sequencing techniques have transformed cancer treatment.

Gang Song, Ph.D., CEO & Co-Founder, Pillar Biosciences 08.20.21

Drug Development | Drug Discovery

Antimicrobial Resistance ‘Arms Race’ Realizes Advancements as Post-Antibiotic Era Ensues

Emerging innovations and non-antibiotic approaches to address urgent need to control infectious diseases, including multiple-drug resistant ‘super-bugs’

Merilee Kern 08.18.21

Clinical Trials | Information Technology

Enabling Decentralized Clinical Trials through Digital Transformation

Adopting a strategy of “bringing the technology to the data.”

Temitope Keyes, Executive Director, Business Development at Cmed Technology 08.17.21

Clinical Trials | Cold Chain Management | Logistics

Flexible Ultracold Chain Critical to Decentralized Clinical Trials

Addressing barriers to further grow and accelerate the adoption of patient-focused DCTs.

Timothy Root, Marketing Director, Stirling Ultracold 08.12.21

Biologics, Proteins, Vaccines | cGMP Manufacture

A Look Into COVID Vaccines, Development and Outsourcing

Fiona Barry of PharmSource discusses COVID vaccines in development and CMO outsourcing trends.

08.09.21

Clinical Trials | Information Technology

Leveraging Clinical Trial Outcomes Through Medication Adherence

Addressing adherence and trial failure, the problem with traditional methods, and the smart way to monitor adherence.

Bernard Vrijens, CEO & Scientific Lead, AARDEX Group 08.05.21

The Real Cost of Bringing Manufacturing Home

Bikash Chatterjee of Pharmatech Associates discusses the reshoring trend, technologies and advances that could help deliver more manufacturing back to the U.S.

08.04.21

Biologics, Proteins, Vaccines | Drug Development